NCT00415428已完成不适用
Patient And Physician Alliance -Guideline Education Treatment Optimization
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.0 个研究点目标入组 2,776 人开始时间: 2007年1月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 2,776
研究概览
简要总结
The overall objective is to increase the adherence to national guidelines for patients with established CVD and/or Type 2 diabetes by means of repeated post-graduate educational meetings and regular evaluation of the optimisation initiatives, demonstrated by improvement of goal attainment in general practice.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subjects had to meet all of the inclusion criteria to be eligible for enrollment into the study. The following subjects qualify for inclusion in the study:
- •Subjects for whom measurement of total cholesterol, low density lipoprotein (LDL) cholesterol, blood pressure (BP) and glycosylated hemoglobin (HbA1c) was planned independently of this observational study and for whom baseline values were or became available.
- •Subjects with known CVD diagnosed > or = 6 months before inclusion
- •Previous myocardial infarction
- •Ischemic heart disease (stable and unstable angina pectoris)
- •Ischemic apoplexy
- •Peripheral arterial disease
- •Subjects with T2D diagnosed > or = 6 months before inclusion
- •At least 50% of the subjects had to have CVD as the primary diagnosis. It was allowed for a secondary diagnosis to be <6 months before inclusion.
排除标准
- •Subjects presenting with any of the following were not to be included in the study:
- •Life expectancy of < or = 2 years
- •Unable/unwilling to understand/follow instructions
- •Taking part in a clinical study involving an investigational drug
- •Followed by a specialist for their CVD and/or T2D at the time of inclusion in the study
研究者
相似试验
进行中(未招募)
不适用
The PRIME-CRC Trial to Promote CRC Screening in Rural CommunitiesColorectal CancerNCT04313114Louisiana State University Health Sciences Center Shreveport804
已完成
不适用
Increasing Medication Adherence Through Physician Incentives and MessagingMedication AdherenceNCT01603329National Bureau of Economic Research, Inc.734
已完成
不适用
Optimizing guideline adherence of rheumatologistsRheumatoid arthritis, guideline adherenceNL-OMON21693Department of Rheumatology, Sint Maartenskliniek, Nijmegen, the Netherlands20
已完成
不适用
IMPlementation of gUideLines for the Management of Arterial hypertenSION. The IMPULSION StudyHigh Blood PressureNCT00416611Hellenic Atherosclerosis Society1,000
已完成
1 期
Addressing Unmet Basic Needs to Improve Adherence Among Women With an Abnormal PapAbnormal Pap SmearColposcopyNCT03317470Washington University School of Medicine96
